Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

A Randomized Controlled Trial of the Effects of Mindfulness-Based Stress Reduction (MBSR[BC]) on Levels of Inflammatory Biomarkers Among Recovering Breast Cancer Survivors.

Reich RR, Lengacher CA, Klein TW, Newton C, Shivers S, Ramesar S, Alinat CB, Paterson C, Le A, Park JY, Johnson-Mallard V, Elias M, Moscoso M, Goodman M, Kip KE.

Biol Res Nurs. 2017 Jul;19(4):456-464. doi: 10.1177/1099800417707268. Epub 2017 May 1.

2.

Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles.

Williams JC, Klein TW, Goldberger BA, Sleasman JW, Mackman N, Goodenow MM.

J Inflamm (Lond). 2015 Jun 12;12:39. doi: 10.1186/s12950-015-0084-1. eCollection 2015.

3.

Controlled hydrogenative depolymerization of polyesters and polycarbonates catalyzed by ruthenium(II) PNN pincer complexes.

Krall EM, Klein TW, Andersen RJ, Nett AJ, Glasgow RW, Reader DS, Dauphinais BC, Mc Ilrath SP, Fischer AA, Carney MJ, Hudson DJ, Robertson NJ.

Chem Commun (Camb). 2014 May 18;50(38):4884-7. doi: 10.1039/c4cc00541d.

PMID:
24647792
4.

Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Williams JC, Appelberg S, Goldberger BA, Klein TW, Sleasman JW, Goodenow MM.

J Neuroimmune Pharmacol. 2014 Jun;9(3):369-79. doi: 10.1007/s11481-014-9527-3. Epub 2014 Feb 23.

5.

Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients.

Reich RR, Lengacher CA, Kip KE, Shivers SC, Schell MJ, Shelton MM, Widen RH, Newton C, Barta MK, Paterson CL, Farias JR, Cox CE, Klein TW.

Biol Res Nurs. 2014 Oct;16(4):429-37. doi: 10.1177/1099800413519494. Epub 2014 Jan 28.

6.

Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.

Newton CA, Klein TW.

J Neuroimmune Pharmacol. 2012 Sep;7(3):591-8. doi: 10.1007/s11481-012-9361-4. Epub 2012 May 4.

7.

Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy.

Lengacher CA, Kip KE, Post-White J, Fitzgerald S, Newton C, Barta M, Jacobsen PB, Shelton MM, Moscoso M, Johnson-Mallard V, Harris E, Loftus L, Cox C, Le N, Goodman M, Djeu J, Widen RH, Bercu BB, Klein TW.

Biol Res Nurs. 2013 Jan;15(1):37-47. doi: 10.1177/1099800411419245. Epub 2011 Nov 14.

PMID:
22084404
8.

Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes.

Sherwood TA, Nong L, Agudelo M, Newton C, Widen R, Klein TW.

J Neuroimmune Pharmacol. 2009 Dec;4(4):476-88. doi: 10.1007/s11481-009-9169-z. Epub 2009 Sep 16.

9.

Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.

Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE.

Psychooncology. 2009 Dec;18(12):1261-72. doi: 10.1002/pon.1529.

PMID:
19235193
10.

Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested.

Chou PJ, Newton CA, Perkins I, Friedman H, Klein TW.

DNA Cell Biol. 2008 Dec;27(12):637-48. doi: 10.1089/dna.2008.0760.

11.

CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.

Newton CA, Chou PJ, Perkins I, Klein TW.

J Neuroimmune Pharmacol. 2009 Mar;4(1):92-102. doi: 10.1007/s11481-008-9126-2. Epub 2008 Sep 16.

PMID:
18792785
12.

In memory of Billy R. Martin (1943-2008).

Klein TW, Peterson P, Cabral G, Kaminski N, Adler M.

J Neuroimmune Pharmacol. 2008 Dec;3(4):201-2. doi: 10.1007/s11481-008-9122-6. Epub 2008 Aug 22. No abstract available.

PMID:
18720014
13.

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.

Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H, Klein TW.

J Neuroimmune Pharmacol. 2008 Mar;3(1):35-42. doi: 10.1007/s11481-007-9088-9. Epub 2007 Sep 27.

14.

Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.

Klein TW, Cabral GA.

J Neuroimmune Pharmacol. 2006 Mar;1(1):50-64. Review.

PMID:
18040791
15.

Therapeutic potential of cannabinoid-based drugs.

Klein TW, Newton CA.

Adv Exp Med Biol. 2007;601:395-413. Review.

PMID:
17713029
16.

Differential effects of Chlamydia pneumoniae infection on cytokine levels in human T lymphocyte- and monocyte-derived cell cultures.

Mamata Y, Hakki A, Newton C, Burdash N, Klein TW, Friedman H.

Int J Med Microbiol. 2007 Apr;297(2):109-15. Epub 2007 Feb 5.

PMID:
17280867
17.
18.

Addictive drugs and their relationship with infectious diseases.

Friedman H, Pross S, Klein TW.

FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42. Review.

19.

Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection.

Lu T, Newton C, Perkins I, Friedman H, Klein TW.

J Pharmacol Exp Ther. 2006 Oct;319(1):269-76. Epub 2006 Jul 12.

PMID:
16837556
20.

Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.

Lu T, Newton C, Perkins I, Friedman H, Klein TW.

Eur J Pharmacol. 2006 Feb 17;532(1-2):170-7. Epub 2006 Jan 27.

PMID:
16443217
21.
22.

Cannabinoid-based drugs as anti-inflammatory therapeutics.

Klein TW.

Nat Rev Immunol. 2005 May;5(5):400-11. Review.

PMID:
15864274
23.

Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells.

Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, Friedman H.

Int Immunopharmacol. 2005 Apr;5(4):749-56.

PMID:
15710343
24.

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.

Medveczky MM, Sherwood TA, Klein TW, Friedman H, Medveczky PG.

BMC Med. 2004 Sep 15;2:34.

25.

The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2.

Newton CA, Lu T, Nazian SJ, Perkins I, Friedman H, Klein TW.

J Leukoc Biol. 2004 Oct;76(4):854-61. Epub 2004 Jul 16.

PMID:
15258190
26.

Cannabinoid receptors and T helper cells.

Klein TW, Newton C, Larsen K, Chou J, Perkins I, Lu L, Nong L, Friedman H.

J Neuroimmunol. 2004 Feb;147(1-2):91-4.

PMID:
14741435
27.
28.

The cannabinoid system and immune modulation.

Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H.

J Leukoc Biol. 2003 Oct;74(4):486-96. Epub 2003 Jul 1. Review.

PMID:
12960289
29.

Microbial infections, immunomodulation, and drugs of abuse.

Friedman H, Newton C, Klein TW.

Clin Microbiol Rev. 2003 Apr;16(2):209-19. Review.

30.

Legionella pneumophila pathogenesis and immunity.

Friedman H, Yamamoto Y, Klein TW.

Semin Pediatr Infect Dis. 2002 Oct;13(4):273-9. Review.

PMID:
12491233
31.

Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection.

Resto-Ruiz SI, Schmiederer M, Sweger D, Newton C, Klein TW, Friedman H, Anderson BE.

Infect Immun. 2002 Aug;70(8):4564-70.

33.

Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers.

Nong L, Newton C, Cheng Q, Friedman H, Roth MD, Klein TW.

J Neuroimmunol. 2002 Jun;127(1-2):169-76.

PMID:
12044989
34.

Cannabinoids and the immune system.

Klein TW, Newton CA, Friedman H.

Pain Res Manag. 2001 Summer;6(2):95-101. Review.

PMID:
11854771
35.
36.

CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types.

Nong L, Newton C, Friedman H, Klein TW.

Adv Exp Med Biol. 2001;493:229-33.

PMID:
11727770
37.
38.

Modulation of CB1 mRNA upon activation of murine splenocytes.

Noe SN, Newton C, Widen R, Friedman H, Klein TW.

Adv Exp Med Biol. 2001;493:215-21.

PMID:
11727768
40.

Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation.

Lee SF, Newton C, Widen R, Friedman H, Klein TW.

Eur J Pharmacol. 2001 Jul 6;423(2-3):235-41.

PMID:
11448490
42.

Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice.

Salins S, Newton C, Widen R, Klein TW, Friedman H.

Infect Immun. 2001 Jun;69(6):3605-10.

43.

Alveolar macrophage cell line MH-S is valuable as an in vitro model for Legionella pneumophila infection.

Matsunaga K, Klein TW, Friedman H, Yamamoto Y.

Am J Respir Cell Mol Biol. 2001 Mar;24(3):326-31.

PMID:
11245632
44.

Legionella pneumophila suppresses interleukin-12 production by macrophages.

Matsunaga K, Klein TW, Newton C, Friedman H, Yamamoto Y.

Infect Immun. 2001 Mar;69(3):1929-33.

45.

Differential expression of IL-1 and TNF receptors in murine macrophages infected with virulent vs. avirulent Legionella pneumophila.

McHugh S, Yamamoto Y, Klein TW, Friedman H.

Can J Microbiol. 2000 Oct;46(10):885-91.

PMID:
11068674
46.

Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes.

Noe SN, Newton C, Widen R, Friedman H, Klein TW.

J Neuroimmunol. 2000 Oct 2;110(1-2):161-7.

PMID:
11024546
47.

The cannabinoid system and cytokine network.

Klein TW, Lane B, Newton CA, Friedman H.

Proc Soc Exp Biol Med. 2000 Oct;225(1):1-8. Review.

PMID:
10998193
49.

Helicobacter pylori infection of human gastric epithelial cells induces IL-8 and TNFalpha, but not TGFbeta1 mRNA.

Nakachi N, Klein TW, Friedman H, Yamamoto Y.

FEMS Immunol Med Microbiol. 2000 Sep;29(1):23-6.

50.

Tumor necrosis factor induces resistance of macrophages to Legionella pneumophila infection.

McHugh SL, Newton CA, Yamamoto Y, Klein TW, Friedman H.

Proc Soc Exp Biol Med. 2000 Jul;224(3):191-6.

PMID:
10865236

Supplemental Content

Loading ...
Support Center